We have other tools in the toolbox for treating obesity if someone hasn't achieved weight loss with a GLP-1
Semaglutide Misuse in Atypical Anorexia Nervosa-A Case Report
Rare but serious risks of Zepbound and Ozempic Both medications come with similar warnings and potential health complications, though these are rare
The presence of obesity-related complications such as obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), or cardiovascular disease may justify longer treatment duration given the health benefits of sustained weight loss
10.1007/s11892-013-0378-8 162 ZelnikerT
Wegovy, a brand name of semaglutide, has been associated with these side effects: Nausea and vomiting Diarrhea or constipation Stomach pain or indigestion Decreased appetite leading to weight loss Fatigue and dizziness Increased heart rate Insomnia (difficulty sleeping) In rare cases, patients may also experience: Tremors and feelings of anxiety or nervousness